Farm Animal Anesthesia. Группа авторов

injection of xylazine for perineal analgesia in horses. Journal of the American Veterinary Medical Association 193: 1405–1408.

      106 106 Fikes, L., Lin, H., and Thurmon, J. (1989). A preliminary comparison of lidocaine and xylazine as epidural analgesics in ponies. Veterinary Surgery & Anesthesia 18: 85–86.

      107 107 Ko, J., Althouse, G., Hopkins, S. et al. (1989). Effects of epidural administration of xylazine or lidocaine on bovine uterine motility and perineal analgesia. Theriogenology 32: 779–786.

      108 108 Aziz, M. and Martin, R. (1978). Alpha agonist and local anaesthetic properties of xylazine. Zentralblatt fur Veterinarmedizin. Reihe A 25: 181–188.

      109 109 Sakaguchi, M., Nishimura, R., Sasaki, N. et al. (1992). Sedative effects of medetomidine in pigs. The Journal of Veterinary Medical Science 54: 643–647.

      110 110 Sakaguchi, M., Nishimura, R., Sasaki, N. et al. (1996). Anesthesia induced in pigs by use of a combination of medetomidine, butorphanol and ketamine and its reversal by administration of atipamezole. American Journal of Veterinary Research 57: 529–534.

      111 111 vanMiert, A., Faghihi, S., and vanDuin, C. (1994). Food intake and rumen motility in dwarf goats. Effects of atipamezole on the inhibitory effects induced by detomidine, medetomidine, and romifidine. Veterinary Research Communications 18: 457–469.

      112 112 Yellin, T., Sperow, J., and Buck, S. (1975). Antagonism of tolazoline by histamine H2‐receptor blockers. Nature 253: 561–563.

      113 113 Read, M., Duke, T., and Toews, A. (2000). Suspected tolazoline toxicosis in a llama. Journal of the American Veterinary Medical Association 216: 227–229.

      114 114 Lin, H. and Riddell, M. (2008). Tolazoline: dose responses and side effects in non‐sedated Holstein calves. The Bovine Practitioner 42: 86–96.

      115 115 Anderson, D. (2011). New methods for chemical restraint and field anesthesia in cattle. In: North American Veterinary Community Conference, Orlando, FL, USA, 6–11.

      116 116 Carroll, G., Hartsfield, S., Champney, T. et al. (2005). Effect of medetomidine and its antagonism with atipamezole on stress‐related hormone, metabolites, physiologic responses, sedation, and mechanical threshold in goats. Veterinary Anaesthesia and Analgesia 32: 147–157.

      117 117 Clineschmidt, B., Pettibone, D., Lotti, V. et al. (1988). A peripherally acting alpha‐2 adrenoceptor antagonist: L659,066. Journal of Pharmacology and Experimental Therapeutics 245: 32–40.

      118 118 Honakvaara, J., Resititutti, F., Rackallio, M. et al. (2011). The effects of increasing doses of MK‐467, a peripheral alpha2‐adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs. Journal of Veterinary Pharmacology & Therapeutics 34: 332–337.

      119 119 Rolfe, N., Kerr, C., and McDonell, W. (2012). Cardiopulmonary and sedative effects of the peripheral α2‐adrenoceptorantagonist MK‐0467 administered intravenously concurrently with medetomidine in dogs. American Journal of Veterinary Research 73: 587–594.

      120 120 Salla, K., Restittuti, F., Vainionpää, M. et al. (2014). The cardiopulmonary effects of the peripheral alpha‐2‐adrenoceptor antagonist, MK‐467, in dogs sedated with a combination of medetomidine and butorphanol. Veterinary Anaesthesia and Analgesia 41: 567.

      121 121 Restittuti, F., Honakvaara, J., Raekallio, M. et al. (2011). Effects of different doses of L‐659′066 on bispectral index and clinical sedation in dogs treated with dexmedetomidine. Veterinary Anaesthesia and Analgesia 38: 415–422.

      122 122 Honkavaara, J., Pypendop, B., Turunen, H. et al. (2017). The effect of MK‐467, a peripheral α2‐adrenoceptor antagonist, on dexmedetomidine‐induced sedation and bradycardia after intravenous administration in conscious cats. Veterinary Anaesthesia and Analgesia 44: 42–51.

      123 123 Vainionpää, M., Rackallio, M., Pakkanen, S. et al. (2013). Plasma drug concentrations and clinical effects of a peripheral alpha‐2‐adrenoceptor antagonist, MK‐467, in horses sedated with detomidine. Veterinary Anaesthesia and Analgesia 40: 257–264.

      124 124 de Vries, A., Pakkanen, S., Rackallio, M. et al. (2016). Clinical effects and plasma drug concentrations of romifidine and the peripheral α‐2‐adrenoceptor antagonist MK‐467 in horses. Veterinary Anaesthesia and Analgesia 43: 599–610.

      125 125 Rackallio, M., Honkavaara, J., and Vainio, O. (2010). The effects of L‐659,066, a peripheral α2‐adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep. Journal of Veterinary Pharmacology and Therapeutics 33: 434–438.

      126 126 Restittuti, F., Kaartinen, J., Raekallio, M. et al. (2017). Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha2‐antagonist MK‐467 in dogs. Veterinary Anaesthesia and Analgesia 44: 417–426.

      127 127 Hakavaara, J., Restitutti, F., Raekallio, M. et al. (2012). Influence of MK‐467, a peripherally acting α2‐adrenoceptor antagonist, on the disposition of intravenous dexmedetomidine in dogs. Drug Metabolism & Disposition 40: 445–449.

      128 128 Adam, M., Raekallio, M., Salla, K. et al. (2018). Effects of the peripherally acting α2‐adrenoceptor antagonist MK‐467 on cardiopulmonary function in sheep sedated by intramuscular administration of medetomidine and ketamine and reversed by intramuscular administration of atipamezole. American Journal of Veterinary Research 79: 921–932.

      129 129 Stoelting, R. and Hillier, S. (2006). Benzodiazepines. In: Pharmacology and Physiology in Anesthetic Practice, 4e, 140–154. Philadelphia: Lippincott Willimas & Wilkins, A Wolters Kluwer Company.

      130 130 Kyles, A., Waterman, A., and Livingston, A. (1995). Antinociceptive activity of midazolam in sheep. Journal of Veterinary Pharmacology and Therapeutics 18: 54–60.

      131 131 Lizarraga, I. and Chambers, J. (2012). Use of analgesics for pain management in sheep. New Zealand Veterinary Journal 60: 87–94.

      132 132 Simon, B., Scallan, E., Ebner, L. et al. (2017). Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep. American Journal of Veterinary Research 78: 539–549.

      133 133 Gray, P. and McDonell, W. (1986). Anesthesia in goats and sheep, part II: general anesthesia. Compendium on Continuing Education 8: S127–S135.

      134 134 Ochs, H., Greenblatt, D., Eichelkraut, W. et al. (1987). Hepatic vs gastrointestinal presystemic extraction of oral midazolam and flurazepam. The Journal of Pharmacology and Experimental Therapeutics 243: 852–856.

      135 135 Penders, K., Pollack, C., Woodall, B., and Parks, B. (1991). Intraoesseous administration of lorazepam: same‐dose comparison with intravenous administration in the weanling pig. Journal of the Mississippi State Medical Association 32 (10): 365–368.

      136 136 Danneberg, P., Bauer, R., Boke‐Kuhn, K. et al. (1986). General pharmacology of brotizolam in animals. Arzneimittel‐Forschung 36: 540–551.

      137 137 Lumb, W. and Jones, E. (1973). Preanesthetic agents. In: Veterinary Anesthesia (eds. W. Lumb and E. Jones), 179–208. Philadelphia: Lea & Fabiger.

      138 138 Lin, H. (2012) Large ruminant anesthesia: review and update. Western Veterinary Conference, Las Vegas, NV, USA. FA#1.

      139 139 Abrahamsen, E. (2009). Chemical restraint, anesthesia, and analgesia for camelids. Veterinary Clinics of North America: Food Animal Practice 25: 455–494.

      140 140 Stegmann, G. and Bester, L. (2001). Sedative‐hypnotic effects of midazolam in goats after intravenous and intramuscular administration. Veterinary Anaesthesia and Analgesia 28: 49–55.

      141 141 Benson, G. and Thurmon, J. (1979). Anesthesia of swine under field conditions. Journal of the American Veterinary Medical Association 174: 594–596.

      142 142 Thurmon, J. and Tranquilli, W. (1986). Anesthesia for cardiovascular research. In: Swine in Cardiovascular Research (eds. H. Stanton and H. Mersmann), 39–59. Boca Raton: CRC Press.

      143 143 Lacoste, L., Bouquet, S., Ingrand, P. et al. (2000). Intranasal midazolam